Place of Prefilled Syringes in COVID-19 Patient Based on Current Evidence
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Malik P, Rangel M, VonBriesen T J Infus Nurs. 2021; 45(1):27-36.
PMID: 34839309 PMC: 8700297. DOI: 10.1097/NAN.0000000000000451.
References
1.
Castle N, Bowen J, Spencer N
. Does wearing CBRN-PPE adversely affect the ability for clinicians to accurately, safely, and speedily draw up drugs?. Clin Toxicol (Phila). 2010; 48(6):522-7.
DOI: 10.3109/15563650.2010.491483.
View
2.
Smereka J, Szarpak L, Filipiak K, Jaguszewski M, Ladny J
. Which intravascular access should we use in patients with suspected/confirmed COVID-19?. Resuscitation. 2020; 151:8-9.
PMC: 7158769.
DOI: 10.1016/j.resuscitation.2020.04.014.
View
3.
Suyama J, Knutsen C, Northington W, Hahn M, Hostler D
. IO versus IV access while wearing personal protective equipment in a HazMat scenario. Prehosp Emerg Care. 2007; 11(4):467-72.
DOI: 10.1080/10903120701536982.
View
4.
Ewy G, Bobrow B, Chikani V, Sanders A, Otto C, Spaite D
. The time dependent association of adrenaline administration and survival from out-of-hospital cardiac arrest. Resuscitation. 2015; 96:180-5.
DOI: 10.1016/j.resuscitation.2015.08.011.
View
5.
Schumacher J, Arlidge J, Garnham F, Ahmad I
. A randomised crossover simulation study comparing the impact of chemical, biological, radiological or nuclear substance personal protection equipment on the performance of advanced life support interventions. Anaesthesia. 2017; 72(5):592-597.
DOI: 10.1111/anae.13842.
View